RECIST 1.1 Compared With RECIST 1.0 in Patients With Advanced Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor–Targeted Therapy

OBJECTIVE: Response Evaluation Criteria in Solid Tumors (RECIST) is the most widely accepted method to objectively assess response to therapy in renal cell carcinoma (RCC) treated with vascular endothelial growth factor (VEGF)–targeted therapy. Both RECIST 1.0 and 1.1 have been used to assess respon...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:AJR Am J Roentgenol
Main Authors: Krajewski, Katherine M., Nishino, Mizuki, Ramaiya, Nikhil H., Choueiri, Toni K.
Format: Artigo
Sprog:Inglês
Udgivet: 2015
Fag:
Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4352691/
https://ncbi.nlm.nih.gov/pubmed/25714313
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2214/AJR.14.13236
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker